ANDHealth+ Program 2024

Apr 1 - Jul 31 | Melbourne VIC, Australia | Virtual Program
Advancing the commercialisation of clinically validated digital health technologies.

About this Program

ANDHealth+ is the leading digital health commercialisation program in Australia, with a proven track record of scaling digital health businesses across a broad range of clinical and commercial metrics.

ANDHealth+ has a successful track record in taking businesses to scale, with the 10 companies selected in the pilot ANDHealth+ program raising over $135.3 million in funding, creating 379 new jobs, undertaking 47 clinical studies and impacting over 260,907 patients in just five and a half years.

ANDHealth+ is funded by the Australian Government, Department of Health, Medical Research Future Fund Early Stage Translation and Commercialisation Support Program, with the intent of delivering a measurable impact on the selected SMEs’ ability to deliver new treatments or products to Australian patients, to undertake and provide access for more Australians to clinical trials, and to engage the clinician and patient community in embracing the potential of digital health and to the commercialisation and expansion of Australian digital health SMEs.

ANDHealth+ supports proof-of-concept stage, evidence-based digital health SMEs, which meet the MRFF definition of digital health as follows:

‘technologies that use computing platforms, connectivity, software and sensors, either alone or in combination with physical products, to treat, diagnose, cure, mitigate and/or prevent disease or other conditions. Does not include digital health records, secure messaging, ePrescribing and other national digital health infrastructure.’

SMEs who meet the eligibility criteria and complete the application requirements are assessed via a proven assessment and selection process, with five (up to a maximum of seven) SMEs selected for each cohort.

Selected SMEs will share in up to $3.75M of project funding per intake from the ANDHealth Digital Health Accelerator Fund alongside substantial in-kind services from pre-vetted suppliers and a dedicated ANDHealth support team providing hands-on support to undertake project activities, procure specialist expertise and meet agreed milestones.

This program will run from 1 April 2024 to 31 July 2025.

More information can be found on the ANDHealth website at

Applications close 9am AEDT 5th Feb 2024.

Funding Information

  • Funds up to $1M per team
  • Takes up to 0.0% equity


Healthcare Services, IT Services, Medical Devices and Equipment